Cutaneous symptoms in drug allergy: What have we learnt?

Current Opinion in Allergy and Clinical Immunology

Volumn 9, Issue 5, 2009, Pages 431-436

  Mayorga, Cristobalina ^a   Torres, Maria Jose ^a   Fernandez, Javier ^b   Canto, Gabriela ^c   Blanca, Miguel ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b Elche University Hospital   (Spain)

^c HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

Author keywords

Drug allergy; Immunopathology; Mechanisms; T cells

Indexed keywords

HAPTEN;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; CELL MIGRATION; DISEASE SEVERITY; DRESS SYNDROME; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; FIXED DRUG ERUPTION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INTRACUTANEOUS TEST; LYMPHOCYTE TRANSFORMATION TEST; MACULOPAPULAR RASH; PATCH TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RASH; REVIEW; SKIN ALLERGY; T LYMPHOCYTE ACTIVATION; TOXIC EPIDERMAL NECROLYSIS; URTICARIA;

ANIMALS; BIOLOGICAL MARKERS; CELL COMMUNICATION; CELL MOVEMENT; CYTOTOXICITY TESTS, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY, DELAYED; SKIN; T-LYMPHOCYTES;

EID: 69749106337     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3283307abc     Document Type: Review

References (84)

1. Gruchalla RS. Drug allergy. J Allergy Clin Immunol 2003; 111:548-559.
2. Mayorga C, Pena RR, Blanca-López N, et al. Monitoring the acute phase response in nonimmediate allergic drug reactions. Curr Opin Allergy Clin Immunol 2006; 6:249-257. (Pubitemid 44510180)
3. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 209:123-129.
4. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003; 139:683-693.
5. Fernandez TD, Blanca M. Molecular mechanisms of maculopapular exanthema. Curr Opin Infect Dis 2009; 22:272-278.
6. Roujeau JC, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991; 127:1333-1338.
7. Halevy S. Generalized exanthematous pustulosis (AGEP). Curr Opin Allergy Clin Immunol 2009; 9:322-328.
8. Shiohara T. Fixed drug eruption: pathogenesis and diagnostic tests. Current Opin Allergy Clin Immunol 2009; 9:316-321.
9. Shiohara T, Mizukawa Y, Teraki Y. Pathophysiology of fixed drug eruption: the role of skin-resident T cells. Curr Opin Allergy Clin Immunol 2002; 2:317-323. (Pubitemid 36869640)
10. Rozieres A, Vocanson M, Nosbaum A, et al. Role of T cells in nonimmediate allergic drug reaction. Curr Opin Allergy Clin Immunol 2009; 9:316-321.
11. Chiou CC, Yang LC, Hung SI, et al. Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol 2008; 22:1044-1049.
12. Tsuge I, Okumura A, Kondo Y, et al. Allergen-specific T-cell response in patients with phenytoin hypersensitivity; simultaneous analysis of proliferation and cytokine production by carboxyfluorescein succinimidyl ester (CFSE) dilution assay. Allergol Int 2007; 56:149-155. (Pubitemid 46984243)
13. Torres MJ, Mayorga C, Fernández TD, et al. T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence. Int J Immunopathol Pharmacol 2006; 19:119-130.
14. Torres MJ, Mayorga C, Cornejo-Garcia JA, et al. Monitoring nonimmediate allergic reactions to iodine contrast media. Clin Exp Immunol 2008; 152:233-238. This article provides information on the role of T lymphocytes in contrast media reactions by monitoring the response in peripheral blood and the involved skin.
15. Pichler WJ, Yawalkar N, Britschgi M, et al. Cellular and molecular pathophysiology of cutaneous drug reactions. Am J Clin Dermatol 2002; 3:229-238. (Pubitemid 34615386)
16. Park HJ, Kim HS, Kim HJ, et al. Immunohistochemical characterization of cutaneous drug eruptions by STI571. J Dermatol Sci 2005; 38:9-15.
17. Barbaud AM, Béné MC, Reichert-Penetrat S, et al. Immunocompetent cells and adhesion molecules in 14 cases of cutaneous drug reactions induced with the use of antibiotics. Arch Dermatol 1998; 134:1040-1041. (Pubitemid 28385337)
18. Yawalkar N, ShrikhandeM, Hari Y, et al. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J Allergy Clin Immunol 2000; 106:1171-1176. (Pubitemid 32006273)
19. Hertl M, Bohlen H, Jugert F, et al. Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by beta-lactam antibiotics. J Invest Dermatol 1993; 101:794-799. (Pubitemid 23357487)
20. Rozieres A, Hennino A, Rodet K, et al. Detection and quantification of drug-specific T cells in penicillin allergy. Allergy 2009; 64:534-542.
21. Hertl M, Jugert F, Merk HF. CD8+ dermal T cells from a sulphamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes. Br J Dermatol 1995; 132:215-220.
22. Padial A, Antunez C, Blanca-Lopez N, et al. Nonimmediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test. Clin Exp Allergy 2008; 38:822-828. The role of intradermal testing in a group of well characterized patients with NIRs to betalactams is shown. Sensitivity of skin tests was lower than that estimated in previous studies. (Pubitemid 351559564)
23. Schaerli P, Britschgi M, Keller M, et al. Characterization of human T cells that regulate neutrophilic skin inflammation. J Immunol 2004; 173:2151-2158. (Pubitemid 38971654)
24. Sidoroff A, Halevy S, Bavinck JN, et al. Acute generalized exanthematous pustulosis (AGEP): a clinical reaction pattern. J Cutan Pathol 2001; 28:113-119. (Pubitemid 32112994)
25. Britschgi M, Pichler WJ. Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells. Curr Opin Allergy Clin Immunol 2002; 2:325-331. (Pubitemid 36869641)
26. Britschgi M, Steiner UC, Schmid S, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 2001; 107:1433-1441. (Pubitemid 32522037)
27. Padial MA, Alvarez-Ferreira J, Tapia B, et al. Acute generalized exanthematous pustulosis associated with pseudoephedrine. Br J Dermatol 2004; 150:139-142. (Pubitemid 38234019)
28. Shiohara T, Mizukawa Y. Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells. Eur J Dermatol 2007; 17:201-208. (Pubitemid 46847781)
29. Mizukawa Y, Yamazaki Y, Shiohara T. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption. Br J Dermatol 2008; 158:1230-1238.
30. Mizukawa Y, Shiohara T. Fixed drug eruption: a prototypic disorder mediated by effector memory T cells. Curr Allergy Asthma Rep 2009; 9:71-77.
31. Chung WH, Hung SI, Yang JY, et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008; 14:1343-1350. This manuscript provides information about the role of granulysin in the development of the lesions of TEN.
32. Wu Y, Farrell J, Pirmohamed M, et al. Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity. J Allergy Clin Immunol 2007; 119:973-981.
33. Posadas SJ, Leyva L, Torres MJ, et al. Subjects with allergic reactions to drugs show polarized patterns of cytokine expression depending on the chronology of the clinical reaction. J Allergy Clin Immunol 2000; 106:769-776. (Pubitemid 30799733)
34. Cornejo-Garcia JA, Fernandez TD, Torres MJ, et al. Differential cytokine and transcription factor expression in patients with allergic reactions to drugs. Allergy 2007; 62:1429-1438.
35. Leyva L, Torres MJ, Posadas S, et al. Anticonvulsant-induced toxic epidermal necrolysis: monitoring the immunologic response. J Allergy Clin Immunol 2000; 105:157-165. (Pubitemid 30059116)
36. Mayorga C, Torres MJ, Corzo JL, et al. Improvement of toxic epidermal necrolysis after the early administration of a single high dose of intravenous immunoglobulin. Ann Allergy Asthma Immunol 2003; 91:86-91. (Pubitemid 36909605)
37. Nishio D, Izu K, Kabashima K, Tokura Y. T cell populations propagating in the peripheral blood of patients with drug eruptions. J Dermatol Sci 2007; 48:25-33. (Pubitemid 47284803)
38. Mauri-Hellweg D, Bettens F, Mauri D, et al. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995; 155:462-472.
39. Schnyder B, Burkhart C, Schnyder-Frutig K, et al. Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals. J Immunol 2000; 164:6647-6654. (Pubitemid 30408852)
40. Nassif A, Bensussan A, Dorothee G, et al. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. J Invest Dermatol 2002; 118:728-733. (Pubitemid 34309997)
41. Nassif A, Bensussan A, Boumsell L, et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 2004; 114:1209-1215. (Pubitemid 39469167)
42. Kunkel EJ, Butcher EC. Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002; 16:1-4.
43. Fernandez TD, Mayorga C, Torres MJ, et al. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs. Allergy 2008; 63:712-719. A detailed description of the different lymphocyte subpopulations with the different chemokines and their corresponding ligands is presented. (Pubitemid 351591846)
44. Homey B, Alenius H, Muller A, et al. CCL27-CCR10 interactions regulate T cell mediated skin inflammation. Nat Med 2002; 8:157-165. (Pubitemid 34155127)
45. Boorsma DM, van Beek PJ, Nieboer C, et al. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 2001; 194:398-405. (Pubitemid 32782663)
46. Yawalkar N, Egli F, Hari Y, et al. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy 2000; 30:847-855. (Pubitemid 30341287)
47. Tapia B, Padial A, Sánchez-Sabaté E, et al. Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions. J Allergy Clin Immunol 2004; 114:335-340. (Pubitemid 39119033)
48. Teraki Y, Moriya N, Shiohara T. Drug-induced expression of intercellular adhesion molecule-1 on lesional keratinocytes in fixed drug eruption. Am J Pathol 1994; 145:550-560. (Pubitemid 24285963)
49. Gaspard I, Guinnepain MT, Laurent J, et al. IL-4 and IFN-gamma mRNA induction in human peripheral lymphocytes specific for beta-lactams antibiotics in immediate or delayed hypersensitivity reactions. J Clin Immunol 2000; 20:107-116. (Pubitemid 30314315)
50. Sugita Y, Miyamoto M, Koseki M, et al. Suppression of tumour necrosis factor-(alpha) expression in leprosy skin lesions during treatment for leprosy. Br J Dermatol 1997; 136:393-397. (Pubitemid 27105866)
51. Hertl M, Geisel J, Boecker C, Merk H. Selective generation of CD8- T cell clones from the peripheral blood of patients with cutaneous reactions to beta-lactams antibiotics. Br J Dermatol 1993; 128:619-626. (Pubitemid 23172018)
52. Padovan E, Bauer T, Tongio MM, et al. Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur J Immunol 1997; 27:1303-1307. (Pubitemid 27254817)
53. Thomas E, Bellon T, Barranco P, et al. Acute generalized exanthematous pustulosis due to tetrazepam. J Investig Allergol Clin Immunol 2008; 18:119-122. (Pubitemid 351872305)
54. Paquet P, Pierard GE. Toxic epidermal necrolysis: revisiting the tentative link between early apoptosis and late necrosis. Int J Mol Med 2007; 19:3-10.
55. Fernandez FJ, Puerta R, Gonzalez L, et al. Fever and maculopapular exanthema as first manifestation of lymphoma. Ann Med Interna 2007; 24:204-205.
56. Matsushita T, Hasegawa M, Shirasaki F, et al. A case of acute cutaneous graft versus-host disease mimicking psoriasis vulgaris. Dermatology 2008; 216:64-67. (Pubitemid 350158739)
57. Torres MJ, Corzo JL, Leyva L, et al. Differences in the immunological responses in drug- and virus-induced cutaneous reactions in children. Blood Cells Mol Dis 2003; 30:124-131. (Pubitemid 36378874)
58. Descamps V, Mahe E, Houhou N, et al. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol 2003; 148:1032-1034. (Pubitemid 36750800)
59. González-Delgado P, Blanes M, Soriano V, et al. Erythema multiforme to amoxicillin with concurrent infection by Epstein-Barr virus. Allergol Immunopathol 2006; 34:76-78. (Pubitemid 43844846)
60. LeClaire AC, Martin CA, Hoven AD. Rash associated with piperacillin/tazobactam administration in infectious mononucleosis. Ann Pharmacother 2004; 38:996-998. (Pubitemid 38657742)
61. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 2004; 140:183-188. (Pubitemid 38500330)
62. Rouchouse B, Bonnefoy M, Pallot B, et al. Acute generalized exanthematous pustular dermatitis and viral infection. Dermatologica 1986; 173:180-184. (Pubitemid 16029490)
63. Feio AB, Apetato M, Costa MM, et al. Acute generalized exanthematous pustulosis due to Coxsackie B4 virus. Acta Med Port 1997; 10:487-491.
64. Haro-Gabaldon V, Sanchez-Sanchez-Vizcaino J, Ruiz-Avila P, et al. Acute generalized exanthematous pustulosis with cytomegalovirus infection. Int J Dermatol 1996; 35:735-737. (Pubitemid 26356128)
65. Naides SJ, Piette W, Veach LA, et al. Human parvovirus B19-induced vesiculopustular skin eruption. Am J Med 1988; 84:968-972. (Pubitemid 18137422)
66. Manzano S, Guggisberg D, Hammann C, et al. Acute generalized exanthematous pustulosis: first case associated with a Chlamydia pneumoniae infection. Arch Pediatr 2006; 13:1230-1232. (Pubitemid 44348942)
67. Shiohara T, Kano Y. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol 2007; 33:124-133.
68. Waton J, Tréchot P, Loss-Ayav C, et al. Negative predictive value of drug skin tests in investigating cutaneous adverse drug reactions. Br J Dermatol 2009; 160:786-794.
69. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58:854-863. (Pubitemid 37046682)
70. Romano A, Blanca M, Torres MJ, et al. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 2004; 59:1153-1160. (Pubitemid 39389467)
71. Torres MJ, Sánchez-Sabaté E, Alvarez J, et al. Skin test evaluation in nonimmediate allergic reactions to penicillins. Allergy 2004; 59:219-224. (Pubitemid 38250779)
72. Blanca-López N, Zapatero L, Alonso E, et al. Skin testing and drug provocation in the diagnosis of nonimmediate reactions to aminopenicillins in children. Allergy 2009; 64:229-233.
73. Merk HF. Drug skin metabolites and allergic drug reactions. Curr Opin Allergy Clin Immunol 2009; 9:311-315.
74. Bergstrom MA, Ott H, Carlsson A, et al. A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. J Invest Dermatol 2007; 127:1145-1153. (Pubitemid 46625132)
75. Naisbitt DJ, Sanderson LS, Meng X, et al. Investigation of the immunogenicity of diclofenac and diclofenac metabolites. Toxicol Lett 2007; 168:45-50.
76. Uetrecht J. Idiosyncratic drug reactions: current understanding. Annu Rev Pharmacol Toxicol 2007; 47:513-539. (Pubitemid 46272137)
77. Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997; 27:175-181. (Pubitemid 27085418)
78. Naisbitt DJ, Farrell J, Wong G, et al. Characterization of skin homing lamotrigine-specific T-cells from hypersensitive patients. J Allergy Clin Immunol 2003; 111:1393-1403.
79. Naisbitt DJ, Britschgi M, Wong G, et al. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T-cell clones. Mol Pharmacol 2003; 63:732-741. (Pubitemid 36297347)
80. Schnyder B, Pichler WJ. Skin and laboratory tests in amoxicillin- and penicillin-induced morbilliform skin eruption. Clin Exp Allergy 2000; 30:590-595. (Pubitemid 30253200)
81. Luque I, Leyva L, Torres M, et al. In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 2001; 56:611-618.
82. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004; 59:809-820. (Pubitemid 39005820)
83. Rodriguez-Pena R, Lopez S, Mayorga C, et al. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams. J Allergy Clin Immunol 2006; 118:949-956. (Pubitemid 44498760)
84. Lopez S, Torres MJ, Rodríguez-Pena R, et al. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins. Br J Dermatol 2009; 160:259-265.